Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Digestive System Diseases

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Digestive System Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gabryelewicz, A; Rydzewska, G1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Digestive System Diseases

ArticleYear
[Platelet activating factor (PAF) and its inhibitors].
    Polskie Archiwum Medycyny Wewnetrznej, 1988, Volume: 80, Issue:1

    Topics: Anaphylaxis; Cardiovascular Diseases; Digestive System Diseases; Histamine H1 Antagonists; Histamine Release; Humans; Lignans; Lignin; Platelet Activating Factor; Terpenes

1988